Clinical Trials Logo

Inverse Psoriasis clinical trials

View clinical trials related to Inverse Psoriasis.

Filter by:
  • None
  • Page 1

NCT ID: NCT02695940 Completed - Inverse Psoriasis Clinical Trials

Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis

Start date: March 2016
Phase: Phase 2
Study type: Interventional

This is a phase 2a trial testing twice daily administration of LEO 124249 ointment 30 mg/g in the treatment of mild to moderate inverse psoriasis. Patients will be treated for 6 weeks, and the efficacy and safety will be compared with the treatment of LEO 124249 ointment vehicle.

NCT ID: NCT01574872 Withdrawn - Inverse Psoriasis Clinical Trials

Efficacy of Aerosal® in the Treatment of Inverse Psoriasis and Sebopsoriasis

Start date: March 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy of Aerosal® compared to placebo in the prognosis of inverse psoriasis or sebopsoriasis present for at least one year